Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer

BACKGROUND: Epithelial ovarian cancer (EOC) is a lethal malignant tumor, for which new treatment options are urgently required. Lipolysis-stimulated lipoprotein receptor (LSR) is widely expressed in EOC, and it is associated with poor prognosis. In this study, we developed an antibody-drug conjugate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Mizuki, Serada, Satoshi, Hiramatsu, Kosuke, Funauchi, Masashi, Obata, Kengo, Nakagawa, Satoshi, Ohkawara, Tomoharu, Murata, Okinori, Fujimoto, Minoru, Chiwaki, Fumiko, Sasaki, Hiroki, Ueda, Yutaka, Kimura, Tadashi, Naka, Tetsuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research/Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679668/
https://www.ncbi.nlm.nih.gov/pubmed/36413881
http://dx.doi.org/10.1016/j.neo.2022.100853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679668/
https://www.ncbi.nlm.nih.gov/pubmed/36413881
http://dx.doi.org/10.1016/j.neo.2022.100853

Ejemplares similares